Monograph

S01BC03 - Diclofenac

Not porphyrinogenic

Rationale

Insignificant systemic exposure.

Chemical description

NSAID in eyedrops 1 mg/ml. Recommended daily dose less than 1% of recommended perolral dose. French list: authorized. South African list: use with extreme caution only Kalman, Bonkowsky: unsafe

Similar drugs

Explore alternative drugs in similar therapeutic classes S01B / S01BC or go back.

References

Tradenames

Show more details and information about the listed tradenames

Dicloabak · Diclofenac · Naclof

Dicloabak

Dicloabak · Diclofenaco · Diclofenaco-Lepori · Voltaren

Diclofenac-pp · Voltaren Ophtha

Diclofenac

Dicloabak · Voltaren Ophtha

Voltarol Ophtha · Voltarol Ophtha Multidose

Dicloabak · Voltabak · Voltaren

Voltabak · Voltaren Ophtha

Dicloabak · Diclofitil · Difadol · Naclof

Dicloabak · Voltaren Ophta

Dicloabak · Voltaren Ophtha

Uniclophen

Naclof

In cooperation with IpNet

Acute Porphyria Drugs

Monograph